RBP4 and cryohydrocytosis: The factors consistently associated with RBP4 levels both pre-therapy in CHC patients and at 24 weeks post-therapy in SVR patients, such as BMI, TG, and eGFR, disclosed their fundamental links of RBP4, regardless of HCV infection.